 HOUSTON, May 10, 2022 GLOBE NEWSWIRE -- Alaunos Therapeutics, Inc. Alaunos or the Company Nasdaq: TCRT, a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research Development at Alaunos Therapeutics will present at the upcoming H.C. Wainwright Global Investment Conference being held on May 23-26, 2022 in Miami Beach, FL. 